Executive news intelligence

Signals worth following at the edge of AI and health.

Curated for decision-makers

Six live topic feeds covering the technologies, rules, channels and capital shaping DeepTech health strategy.

Past year · Newest first

News radar

From market noise to relevant strategic signals.

Select a category to focus the radar. Each topic opens a continuously refreshed Google news search in a new tab, limited to the past year and sorted newest first.

Artificial Super Intelligence
01

Beyond AGI: who is advancing toward superintelligence?

Track world models, continual learning, recursive self-improvement and automated scientific discovery beyond conventional LLMs. Follow DeepMind, OpenAI, Anthropic, SSI, Meta and emerging labs—distinguishing demonstrated capabilities from ambitions.

View latest news
Consumer Wearable AI
02

Wearable AI and consumer wellness: latest product and research developments

Track the devices, sensing capabilities and consumer-health experiences shaping the next generation of preventive care.

View latest news
SaMD Regulation
03

Regulatory developments in software for chronic-disease screening and monitoring

Follow evolving expectations for clinical evidence, software lifecycle governance and regulated digital-health claims.

View latest news
Frontier Models for Health
04

Frontier models, LLMs and emerging clinical AI applications

Monitor the capabilities, evidence and deployment questions surrounding frontier and agentic AI in healthcare.

View latest news
Healthcare Channels
05

Digital-health distribution across OEMs, pharma, medical devices and insurers

See how partnerships and distribution models are moving validated health technology into real-world channels.

View latest news
Digital Health Investment
06

Recent venture investments in promising digital-health companies

Follow where strategic and venture capital is flowing across AI-enabled health, evidence platforms and care delivery.

View latest news

External news is provided for informational purposes. Selection does not constitute medical, legal, regulatory or investment advice, nor endorsement of a source or claim.

Turn a signal into a decision

Which development could change your strategy in the next 90 days?

Request a private conversation